A restless entrepreneur and investor, Joachim (MD, PhD) is the founder of HN and Executive Chair of the HN Board. Having started the company in Sweden, he moved his innovation to the UK where it was first deployed as a randomised control trial in collaboration with the Nuffield Trust and NHS Vale of York CCG. Joachim’s career to date has encompassed medicine, academia and business. He worked as an emergency medicine doctor, then moved on to McKinsey&Co international consultancy, then started a successful business in Sweden. Joachim has dedicated almost a decade to researching and implementing solutions that identify and help patients at risk of high levels of unplanned admissions. He holds a PhD from Stockholm’s Karolinska Medical Institute.